Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures

Journal of Neurochemistry

Volumn 73, Issue 1, 1999, Pages 112-119

  Mytilineou, Catherine ^a   Leonardi, Efthimia T Kokotos ^a   Kramer, Brian C ^a   Jamindar, Tejal ^a   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytes; Buthionine sulfoximine; Glutathione; Lipoxygenase; Mesencephalic cultures; Microglia

Indexed keywords

BUTHIONINE SULFOXIMINE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DENSITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GLIA CELL; MESENCEPHALON; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIOXIDANTS; ARACHIDONIC ACID; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CELL COUNT; CELL DEATH; CELLS, CULTURED; EMBRYO; GLUTATHIONE; LIPOXYGENASE INHIBITORS; MESENCEPHALON; NEUROGLIA; NITRIC OXIDE SYNTHASE; NORDIHYDROGUAIARETIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA;

EID: 0344758360     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730112.x     Document Type: Article

References (52)

1. Bronstein D. M., Perez-Otano I., Sun V., Mullis Sawin S. B., Chan J., Wu G. C., Hudson P. M., Kong L. Y., Hong J. S., and McMillian M. K. (1995) Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 704, 112-116.
2. Chao C. C., Hu S., and Peterson P. K. (1996) Glia: the not so innocent bystanders. J. Neurovirol 2, 234-239.
3. Desagher S., Glowinski J., and Premont J. (1996) Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 16, 2553-2562.
4. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
5. Dexter D. T., Jenner P., Schapira A. H., and Marsden C. D. (1992) Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. 32 (Suppl.), S94-S100.
6. Dexter D. T., Sian J., Rose S., Hindmarsh J. G., Mann V. M., Cooper J. M., Wells F. R., Daniel S. E., Lees A. J., Schapira A. H., et al. (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35, 38-44.
7. di Porzio U., Daguet M. C., Glowinski J., and Prochiantz A. (1980) Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature 288, 370-373.
8. Druckarch B., Schepens C. A. M., Jongenelen J. C., Stoof C. H., and Langeveld C. H. (1997) Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency. Brain Res. 770, 123-130.
9. Engele J. and Bohn M. C. (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J. Neurosci. (1992) 12, 685]. J. Neurosci. 11, 3070-3078.
10. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812.
11. 2 and its role in brain tissue. J. Neurochem. 69, 889-901.
12. Giulian D., Vaca K., and Corpuz M. (1993) Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13, 29-37.
13. Han S.-K., Mytilineou C., and Cohen G. (1996) L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem. 66, 501-510.
14. Heales S. J., Bolanos J. P., and Clark J. B. (1996) Glutathione depletion is accompanied by increased neuronal nitric oxide synthase activity. Neurochem. Res. 21, 35-39.
15. Hou J.-G. G., Cohen G., and Mytilineou C. (1997) Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. J. Neurochem. 69, 76-83.
16. Hunot S., Boissiere F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., and Hirsch E. C. (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72, 355-363.
17. Jenner P. and Olanow C. W. (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (Suppl.), S161-S170.
18. Jeohn G. H., Kong L. Y., Wilson B., Hudson P., and Hong J. S. (1998) Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J. Neuroimmunol. 85, 1-10.
19. Kalir H. H. and Mytilineou C. (1991) Ascorbic acid in mesencephalic cultures: effects on dopaminergic neuron development. J. Neurochem. 57, 458-464.
20. Katsuki H. and Okuda S. (1995) Arachidonic acid as a neurotoxic and neurotrophic substance. Prog. Neurobiol. 46, 607-636.
21. +, prevent arachidonic acid toxicity on neuronal cultures. Neuroreport 6, 1101-1104.
22. Korystov Y. N., Dobrovinskaya O. R., Shaposhnikova V. V., and Eidus L. (1996) Role of arachidonic acid metabolism in thymocyte apoptosis after irradiation. FEBS Lett. 388, 238-241.
23. Li Y., Maher P., and Schubert D. (1997) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19, 453-463.
24. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
25. McGeer P. L., Itagaki S., Boyes B. E., and McGeer E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
26. Meister A. (1991) Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 51, 155-194.
27. Merad-Boudia M., Nicole A., Santiard-Baron D., Saille C., and Ceballos-Picot I. (1998) Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem. Pharmacol. 56, 645-655.
28. Michel P. P., Ruberg M., and Agid Y. (1997) Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. J. Neurochem. 69, 1499-1507.
29. Minghetti L. and Levi G. (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54, 99-125.
30. Mogi M., Harada M., Kondo T., Narabayashi H., Riederer P., and Nagatsu T. (1995) Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease. Neurosci. Lett. 193, 129-132.
31. Moore S. A., Yoder E., Murphy S., Dutton G. R., and Spector A. A. (1991) Astrocytes, not neurons, produce docosahexaenoic acid (22:6ω-3) and arachidonic acid (20:4ω-6). J. Neurochem. 56, 518-524.
32. Murphy T. H., Miyamoto M., Sastre A., Schnaar R. L., and Coyle J. T. (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547-1558.
33. Mytilineou C., Han S.-K., and Cohen G. (1993) Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J. Neurochem. 61, 1470-1478.
34. Mytilineou C., Leonardi E. K., Radcliffe P., Heinonen E. H., Han S.-K., Werner P., Cohen G., and Olanow C. W. (1998) Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J. Pharmacol. Exp. Ther. 284, 700-706.
35. +-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Brain Res. 599, 83-97.
36. Perry T. L., Godin D. V., and Hansen S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305-310.
37. Perry V. H. (1994) Modulation of microglia phenotype. Neuropathol. Appl. Neurobiol. 20, 177.
38. Philbert M. A., Beiswanger C. M., Waters D. K., Reuhl K. R., and Lowndes H. E. (1991) Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. Toxicol. Appl. Pharmacol. 107, 215-227.
39. Pileblad E., Eriksson P. S., and Hansson E. (1991) The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem. J. Neural Transm. Gen. Sect. 86, 43-49.
40. Piomelli D. (1993) Arachidonic acid in cell signaling. Curr. Opin. Cell Biol. 5, 274-280.
41. Riederer P., Sofic E., Rausch W. D., Schmidt B., Reynolds G. P., Jellinger K., and Youdim M. B. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520.
42. Sagara J. I., Miura K., and Bannai S. (1993) Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61, 1672-1676.
43. Scow R. O. and Blanchette-Mackie E. J. (1985) Why fatty acids flow in cell membranes. Prog. Lipid Res. 24, 197-241.
44. Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., and Marsden C. D. (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol. 36, 348-355.
45. Simmons M. L. and Murphy S. (1992) Induction of nitric oxide synthase in glial cells. J. Neurochem. 59, 897-905.
46. Slivka A., Mytilineou C., and Cohen G. (1987) Histochemical evaluation of glutathione in brain. Brain Res. 409, 275-284.
47. Snyder S. H. and Bredt D. S. (1991) Nitric oxide as a neuronal messenger. Trends Pharmacol. Sci. 12, 125-128.
48. Sofic E., Lange K. W., Jellinger K., and Riederer P. (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142, 128-130.
49. Takeshima T., Snimoda K., Sauve Y., and Commissiong J. W. (1994) Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture. Neuroscience 60, 809-823.
50. Tang D. G., Chen Y. Q., and Honn K. V. (1996) Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. USA 93, 5241-5246.
51. Tietze F. (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
52. Vernadakis A. (1988) Neuron-glia interrelations. Int. Rev. Neurobiol. 30, 149-224.